Intelligent Bio Solutions completes usability study for FDA submission
Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the completion of a usability study for its Intelligent Fingerprinting Drug Screening System ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
